Form 4: USANA Director Converts RSUs to Common Stock
Insider Transaction Report
USANA Health Sciences Director Gilbert A. Fuller converted 1,057 restricted stock units into common stock on October 23, 2025.
Summary
- Gilbert A. Fuller, a Director of USANA Health Sciences Inc. (USNA), converted 1,057 Restricted Stock Units (RSUs) into an equal number of common stock shares.
- This transaction occurred on October 23, 2025, following the vesting of a portion of his RSU grant.
- As a result, Mr. Fuller now directly beneficially owns 1,057 shares of USNA common stock.
- He continues to hold 2,115 unvested Restricted Stock Units directly.
- The RSUs are part of a grant that vests 25% on specific dates: July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The conversion of Restricted Stock Units into common stock is a routine event for directors and indicates an increase in direct equity ownership, which generally aligns management interests with shareholders. It does not, however, provide new fundamental insights into the company's performance or strategic direction.
Positives
- The conversion of Restricted Stock Units into common stock increases the director's direct ownership in the company, aligning his interests more closely with shareholders.
- This is a routine transaction indicating the fulfillment of an equity compensation plan.
Future Outlook
The remaining 2,115 Restricted Stock Units held by Director Gilbert A. Fuller are scheduled to vest in two equal tranches of 25% on January 22, 2026, and April 23, 2026.
Industry Context
This is a standard insider transaction related to equity compensation, common across publicly traded companies to incentivize and retain key personnel. It does not reflect broader industry trends or competitive shifts.
Stakeholder Impact
- Shareholders: Increased direct ownership by a director may be viewed positively as it aligns management incentives with shareholder value.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- Future vesting of the remaining 2,115 Restricted Stock Units on January 22, 2026, and April 23, 2026.
Key Dates
| Date | Description |
|---|---|
| 2025-07-24 | First 25% vesting date for Restricted Stock Units. |
| 2025-10-23 | Transaction date for the conversion of 1,057 Restricted Stock Units into common stock, coinciding with a 25% vesting date. |
| 2025-10-27 | Date the Form 4 filing was signed and submitted. |
| 2026-01-22 | Third 25% vesting date for Restricted Stock Units. |
| 2026-04-23 | Final 25% vesting date for Restricted Stock Units. |
Recommendation
holdThis Form 4 filing reports a routine insider transaction involving the conversion of Restricted Stock Units into common stock. Such transactions are typically part of a director's compensation plan and do not provide new material information that would warrant a change in investment recommendation. The filing does not reveal any significant operational, financial, or strategic developments for USANA Health Sciences Inc. that would alter its fundamental outlook.
Keywords
USANA, USNA, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Stock Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.